The combination of an experimental mRNA vaccine with an immunotherapy reduced the likelihood of melanoma recurring or causing death by 44% when compared to immunotherapy alone, a new clinical trial shows.
…
in Health
Adding new vaccine type to leading immunotherapy dramatically reduced melanoma recurrence
